Citations

Mayo Clinic

Showing 10 of 108522 citations.

HOCl-producing electrochemical bandage is active in murine polymicrobial wound infection
Fleming, Derek , Bozyel, Ibrahim , Koscianski, Christina, Ozdemir, Dilara , Karau, Melissa J. , Cuello, Luz , Anoy, Md Monzurul Islam , Gelston, Suzanne , Schuetz, Audrey N. , Greenwood‐Quaintance, Kerryl E. , Mandrekar, Jayawant N. , Koscianski, Christina A, Beyenal, H , Patel, Robin , Schuetz, Audrey N , Fleming, Derek , Beyenal, Haluk , Patel, Robin

Microbiology Spectrum | August 20, 2024 | Volume: 12 | Issue: 10 | Pages: No page available

10.1128/spectrum.00626-24 | PMID 39162542 Get It

ABSTRACT Wound infections, exacerbated by the prevalence of antibiotic-resistant bacterial pathogens, necessitate innovative antimicrobial approaches. Polymicrobial infections, often involving Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), present challenges due to biofilm formation and antibiotic resistance. Hypochlorous acid (HOCl), a potent antimicrobial agent, holds promise as an alternative therapy. An electrochemical bandage (e-bandage) that generates HOCl in situ via precise polarization controlled by a miniaturized potentiostat was evaluated for the treatment of murine wound biofilm infections containing both P. aeruginosa with “difficult-to-treat” resistance and MRSA. Previously, HOCl-producing e-bandage was shown to reduce murine wound biofilms containing P. aeruginosa alone. Here, in 5-mm excisional skin wounds containing 48-h biofilms comprising MRSA and P. aeruginosa combined, polarized e-bandage treatment reduced MRSA by 1.1 log 10 CFU/g ( P = 0.026) vs non-polarized e-bandage treatment (no HOCl production), and 1.4 log 10 CFU/g (0.0015) vs Tegaderm only controls; P. aeruginosa was similarly reduced by 1.6 log 10 CFU/g ( P = 0.0032) and 1.6 log 10 CFU/g ( P = 0.0015), respectively. For wounds infected with MRSA alone, polarized e-bandage treatment reduced bacterial load by 1.1 log 10 CFU/g ( P = 0.0048) and 1.3 log 10 CFU/g ( P = 0.0048) compared with non-polarized e-bandage and Tegaderm only, respectively. The e-bandage treatment did not negatively impact wound healing or cause tissue toxicity. The addition of systemic antibiotics did not enhance the antimicrobial efficacy of e-bandages. This study provides additional evidence for the HOCl-producing e-bandage as a novel antimicrobial strategy for managing wound infections, including in the context of antibiotic resistance and polymicrobial infections. IMPORTANCE New approaches are needed to combat the rise of antimicrobial-resistant infections. The HOCl-producing electrochemical bandage (e-bandage) leverages in situ generation of HOCl, a natural biocide, for broad-spectrum killing of wound pathogens. Unlike traditional therapies that may exhibit limited activity against biofilms and antimicrobial-resistant organisms, the e-bandage offers a potent, standalone solution that does not contribute to further resistance or require adjunctive antibiotic therapy. Here, we show the ability of the e-bandage to address polymicrobial infection by antimicrobial resistant clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa , two commonly isolated, co-infecting wound pathogens. Effectiveness of the HOCl-producing e-bandage in reducing pathogen load while minimizing tissue toxicity and avoiding the need for systemic antibiotics underscores its potential as a tool in managing complex wound infections.
Exploring Symptom Management Experiences Among College Students With Type 1 Diabetes Mellitus Using a Theoretical Framework: A Qualitative Study
McFadden, Ny’Nika T. , Chaney, Beth H. , Jaiswal, Jessica , Lovett, Kylie , Carmack, Heather J. , Wilkerson, Amanda H. , Stellefson, Michael

The Science of Diabetes Self-Management and Care | August 20, 2024 | Volume: 50 | Issue: 5 | Pages: 339-351

10.1177/26350106241268412 | PMID 39162332 Get It

Purpose The purpose of this study was to explore symptom management experiences among college students with type 1 diabetes mellitus (T1DM). Limited qualitative data using a theoretical framework exist that explore the self-care behavior processes for symptom management. Methods A qualitative approach was used for this study. The middle-range theory of self care of chronic illness served as a framework for data collection and analysis procedures. Data collection included distributing a survey to collect participants’ demographic and sociodemographic data and utilizing a semi-structured interview guide to conduct one-on-one interviews with 31 participants. Interviews occurred via Zoom (n = 28) and in person (n = 3). Interview transcripts were uploaded in NVivo for data management. The research team created a codebook using theoretical constructs to assist with thematic analysis. Data are representative of a sample whose characteristics include undergraduate students ages 18 to 23 living with T1DM for 2 years or more who attended large, public, 4-year universities located in the southeastern United States. Results Three main themes were created using theoretical constructs: symptom detection experiences, symptom interpretation experiences, and symptom response experiences. Two subthemes were identified for each theme. Participants engaged in symptom management for blood glucose regulation through detecting changes in their blood glucose physiologically and via technology. Additionally, symptom interpretation involved analyzing blood glucose trends and determining common causes of blood glucose changes. Symptom response included immediately addressing hypoglycemia but delayed responses addressing hyperglycemia. Conclusions Challenges were present responding to hypoglycemia; therefore, additional research is warranted to improve symptom response skills.
Deliberations of the Safety Task Force: Risk factors and treatment of adverse events associated with aesthetic injectables
Nikolis, Andreas , Cohen, Joel L. , Enright, Kaitlyn M. , Avelar, Luiz Eduardo Toledo , Beleznay, Katie, Biesman, Brian S. , Cartier, Hugues , Cotofana, Sebastian , Fabi, Sabrina G. , Parada, Meire Brasil, Rzany, Berthold, Wang, Hang, Bromée, Torun, Weiner, Steven C., Avelar, Luiz , Goodman, Greg , Schelke, Leonie , Cotofana, Sebastian , Fitzgerald, Rebecca, Lee, Won , Weiner, Steven

Journal of Cosmetic Dermatology | August 20, 2024 | Volume: 23 | Issue: 11 | Pages: 3551-3564

10.1111/jocd.16476 | PMID 39161297 Get It

AbstractBackgroundThe growing popularity of aesthetic procedures involving fillers, biostimulators, and neurotoxins has prompted concerns about patient safety. To address these concerns, a global Safety Task Force (STF) was formed.AimsThe inaugural STF meeting prioritized vascular compromise prevention and management, guiding clinical trial design and materials for future meetings, and collecting data from experts on current safety methods.MethodsThe STF was formed and consisted of 16 experts from nine different countries, with each possessing distinct expertise in various fields related to aesthetic injectables. Current safety data, protocols, knowledge gaps and future research priorities were discussed and voted upon.ResultsThe establishment of a global database for tracking filler‐related AEs was favored by 93% of participants. Discussions revolved around the database's scope, data standardization, and whether non‐medical contributors should be included. Aspiration as a safety technique garnered support from 73% of participants. Approximately 43% of participants incorporate ultrasound in their injections, with divergent opinions on its impact and potential when used as a standard of practice versus in AE management. Most physicians on the task force incorporated cannula use for some of their injections (93%). There were varying perspectives on treatments for vascular adverse events (VAE), the primary causes, and the adoption of new protocols in the field.ConclusionsThe STF meeting underscored the need for a coordinated effort to address complications related to HA fillers, including VAE management and hyaluronidase protocols. Reliable treatment endpoints were evaluated, but improved measurement methods are needed. Future meetings will focus on addressing delayed complications, furthering safety in this field.
Clues to revising the conventional diagnostic algorithm for endometriosis
Roman, Horace , Chapron, Charles , Golfier, François , Fauvet, R. , Delbos, Léa , Poilblanc, Mathieu, Lavoué, Vincent , Petit, E. , Perotte, Frédérique, Benjoar, Mikhael, Merlot, Benjamin , Dennis, Thomas , Boudy, Anne‐Sophie , Fedida, Benjamin, Lèguevaque, Pierre, Genre, Ludivine, Hennetier, Clothilde, Perrin, Morgane , Lucas, Nicolas, Roger, Claire‐Marie, Chantalat, Élodie , Collinet, Pierre , Descamps, Philippe , Bendifallah, Sofiane , Spiers, Andrew, Wasson, Megan , Rousset, Pascal , Akladios, Cherif Youssef , Crochet, Patrice , Fernandez, Hervé

International Journal of Gynecology & Obstetrics | August 20, 2024 | Volume: 168 | Issue: 1 | Pages: 101-111

10.1002/ijgo.15840 | PMID 39161277 Get It

AbstractEndometriosis is a complex gynecologic disorder characterized primarily by symptoms of pelvic pain, infertility, and altered quality of life. National and international guidelines highlight the diagnostic difficulties and lack of conclusive diagnostic tools for endometriosis. Furthermore, guidelines are becoming questionable at an increasingly rapid rate as new diagnostic techniques emerge. This work aims to provide a knowledge synthesis of the relevance of various diagnostic tools and to assess areas of improvement of conventional algorithms. MEDLINE and Cochrane Library databases were searched from January 2021 to December 2023 using relevant key words. Articles evaluating the diagnostic relevance and performance of various tools were included and independently reviewed by the authors for eligibility. Included studies were assessed using the GRADE and QUADAS‐2 tools. Of the 4204 retrieved articles, 26 were included. While anamnesis and clinical examination do contribute to diagnostic accuracy, their level of evidence and impact on the diagnostic process remains limited. Although imaging techniques are recommended to investigate endometriosis, ultrasonography remains highly operator dependent. Magnetic resonance imaging appears to exhibit higher sensitivities than ultrasound. However, concerns persist with regards to the terminology, anatomical definition of lesions, and accuracies of both ultrasound and magnetic resonance imaging. Recently, several biological markers have been studied and cumulative evidence supports the contribution of noncoding RNAs to the diagnosis of endometriosis. Marginal improvements have been suggested for anamnesis, clinical examination, and imaging examinations. Conversely, some biomarkers, including the saliva microRNA signature for endometriosis, have emerged as diagnostic tools which inspire reflection on the revision of conventional diagnostic algorithms.
Epigenome‐wide association study of prostate cancer in African American men identified differentially methylated genes
Berglund, Anders , Yamoah, Kosj , Falahat, Rana , Kim, Sungjune, Dutil, Julie , Ruiz-Deyá, Gilberto, Sanchez, Carmen Ortiz, Park, Hyun, Banerjee, Hirendra N., Lotan, Tamara, Barry, Kathryn Hughes , Putney, Ryan M. , Kim, Young‐Chul , Chakrabarti, Ratna , Eschrich, Steven A , Kim, Seung Joon , Park, Jong Y , Yamoah, Kosj , Berglund, Anders E , Mulé, James J. , Matta, Jaime L. , Wang, Liang , Banerjee, Hirendra N., Gwede, Clement K. , Kresovich, Jacob K. , Kim, Youngchul, Lin, Hui‐Yi , Dhillon, Jasreman , Park, Jong Y.

Cancer Medicine | August 20, 2024 | Volume: 13 | Issue: 16 | Pages: No page available

10.1002/cam4.70044 | PMID 39162297 Get It

Abstract Introduction Men with African ancestry have the highest incidence and mortality rates of prostate cancer (PCa) worldwide. Methods This study aimed to identify differentially methylated genes between tumor vs. adjacent normal and aggressive vs. indolent PCa in 121 African American patients. Epigenome‐wide DNA methylation patterns in tumor DNA were assessed using the human Illumina Methylation EPIC V1 array. Results Around 5,139 differentially methylated CpG‐sites (q < 0.01, lΔβl > 0.2) were identified when comparing normal vs. tumor, with an overall trend of hypermethylation in prostate tumors. Multiple representative differentially methylated regions (DMRs), including immune‐related genes, such as CD40 , Galectin3 , OX40L , and STING , were detected in prostate tumors when compared to adjacent normal tissues. Based on an epigenetic clock model, we observed that tumors’ total number of stem cell divisions and the stem cell division rate were significantly higher than adjacent normal tissues. Regarding PCa aggressiveness, 2,061 differentially methylated CpG‐sites (q < 0.05, lΔβl > .05) were identified when the grade group (GG)1 was compared with GG4/5. Among these 2,061 CpG sites, 155 probes were consistently significant in more than one comparison. Among these genes, several immune system genes, such as COL18A1 , S100A2 , ITGA4 , HLA‐C , and ADCYAP1 , have previously been linked to tumor progression in PCa. Conclusion Several differentially methylated genes involved in immune‐oncologic pathways associated with disease risk or aggressiveness were identified. In addition, 261 African American‐specific differentially methylated genes related to the risk of PCa were identified. These results can shedlight on potential mechanisms contributing to PCa disparities in the African American Population.
Molecular Susceptibility and Treatment Challenges in Melanoma
Kolathur, Kiran Kumar , Nag, Radhakanta , Shenoy, P. , Malik, Yagya, Varanasi, Sai Manasa , Angom, Ramcharan Singh , Mukhopadhyay, Debabrata , Shenoy, Prathvi V , Mukhopadhyay, Debabrata , Singh Angom, Ramcharan

Cells | August 20, 2024 | Volume: 13 | Issue: 16 | Pages: 1383

10.3390/cells13161383 | PMID 39195270 Get It

Melanoma is the most aggressive subtype of cancer, with a higher propensity to spread compared to most solid tumors. The application of OMICS approaches has revolutionized the field of melanoma research by providing comprehensive insights into the molecular alterations and biological processes underlying melanoma development and progression. This review aims to offer an overview of melanoma biology, covering its transition from primary to malignant melanoma, as well as the key genes and pathways involved in the initiation and progression of this disease. Utilizing online databases, we extensively explored the general expression profile of genes, identified the most frequently altered genes and gene mutations, and examined genetic alterations responsible for drug resistance. Additionally, we studied the mechanisms responsible for immune checkpoint inhibitor resistance in melanoma.
Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Gopalasingam, Nigopan , Berg‐Hansen, Kristoffer , Christensen, Kristian Hylleberg, Ladefoged, Bertil , Borlaug, Barry A. , Nielsen, Roni , Møller, Niels , Møller, Niels , Ladefoged, Bertil T , Andersen, Mads Jønsson , Borlaug, Barry A , Nielsen, Roni , Møller, Niels , Wiggers, Henrik , Møller, Niels , Poulsen, Steen Hvitfeldt , Andersen, Mads J.

Circulation | August 20, 2024 | Volume: 150 | Issue: 20 | Pages: 1570-1583

10.1161/circulationaha.124.069732 | PMID 39162035 Get It

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a major cause of morbidity and mortality in patients with type 2 diabetes (T2D). Acute increases in circulating levels of ketone body 3-hydroxybutyrate have beneficial acute hemodynamic effects in patients without T2D with chronic heart failure with reduced ejection fraction. However, the cardiovascular effects of prolonged oral ketone ester (KE) treatment in patients with T2D and HFpEF remain unknown. METHODS: A total of 24 patients with T2D and HFpEF completed a 6-week randomized, double-blind crossover study. All patients received 2 weeks of KE treatment (25 g D-ß-hydroxybutyrate-(R)-1,3-butanediol × 4 daily) and isocaloric and isovolumic placebo, separated by a 2-week washout period. At the end of each treatment period, patients underwent right heart catheterization, echocardiography, and blood samples at trough levels of intervention, and then during a 4-hour resting period after a single dose. A subsequent second dose was administered, followed by an exercise test. The primary end point was cardiac output during the 4-hour rest period. RESULTS: During the 4-hour resting period, circulating 3-hydroxybutyrate levels were 10-fold higher after KE treatment (1010±56 µmol/L; P <0.001) compared with placebo (91±55 µmol/L). Compared with placebo, KE treatment increased cardiac output by 0.2 L/min (95% CI, 0.1 to 0.3) during the 4-hour period and decreased pulmonary capillary wedge pressure at rest by 1 mm Hg (95% CI, –2 to 0) and at peak exercise by 5 mm Hg (95% CI, –9 to –1). KE treatment decreased the pressure-flow relationship (∆ pulmonary capillary wedge pressure/∆ cardiac output) significantly during exercise ( P <0.001) and increased stroke volume by 10 mL (95% CI, 0 to 20) at peak exercise. KE right-shifted the left ventricular end-diastolic pressure-volume relationship, suggestive of reduced left ventricular stiffness and improved compliance. Favorable hemodynamic responses of KE treatment were also observed in patients treated with sodium-glucose transporter-2 inhibitors and glucagon-like peptide-1 analogs. CONCLUSIONS: In patients with T2D and HFpEF, a 2-week oral KE treatment increased cardiac output and reduced cardiac filling pressures and ventricular stiffness. At peak exercise, KE treatment markedly decreased pulmonary capillary wedge pressure and improved pressure-flow relationship. Modulation of circulating ketone levels is a potential new treatment modality for patients with T2D and HFpEF. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT05236335.
Pigmentary Changes in Systemic Sclerosis are Associated with More Severe Cutaneous Sclerosis and Severity of Other Systems: A Cross-sectional Study from India
Mittal, Setu , Khaitan, Binod K., Ramam, M , Bhalla, Ashu Seith , Singh, Manoj K., Sreenivas, Vishnubhatla , Mittal, Setu , Khanna, Neena , Mahajan, Rahul, Sreenivas, Vishnubhatla

Indian Journal of Dermatology | August 20, 2024 | Volume: 69 | Issue: 4 | Pages: 365-365

10.4103/ijd.ijd_251_24 | PMID 39296704 Get It

Abstract Background: Pigmentary changes of the skin in systemic sclerosis in the form of diffuse hyperpigmentation and salt-and-pepper pigmentation are well documented in the literature; however, its association with disease severity and extent of underlying internal organ involvement has not been well studied. Aims: To assess the correlation between morphology and extent of pigmentary changes with the degree of cutaneous sclerosis and frequency and degree of major organ involvement. Methods: This was a cross-sectional descriptive study conducted in a tertiary care teaching hospital from December 2014 to November 2016. Consecutive patients of systemic sclerosis attending the outpatient department were screened, and patients satisfying the diagnosis as per the American Rheumatism Association criteria were recruited. Skin sclerosis was quantified using modified Rodnan skin score (MRSS), whereas pigmentary changes were calculated in terms of percentage of body surface area involved by rule-of-nine method. Investigations were carried out depending on organ involvement and as per respective specialty consultations with focus on pulmonary, cardiac, and gastrointestinal systems. Results: Of the 50 patients recruited, all had cutaneous involvement in the form of binding down of skin, followed by pigmentary changes. MRSS was significantly higher in patients with any pigmentary alteration ( P = 0.03) compared to those without any pigmentary changes. There was a rising trend in between the MRSS severity and the proportion of patients with hyperpigmentation, and it was statistically significant ( P = 0.04). Among systemic involvement, lung was involved in the form of interstitial lung disease in 94% patients (n = 47). However, skin pigmentation of any type was associated with lower high-resolution computed tomography scores ( P = 0.02). Conclusion: This study shows that in systemic sclerosis patients presenting with pigmentary skin manifestations, cutaneous sclerosis is significantly higher.
Trends and Age–Period–Cohort Effect on the Incidence of Early-Onset Colorectal Cancer (20–44 Years) from 1990 to 2021 in the United States
Wallace, Michael B. , Bhagavathula, Akshaya Srikanth , Aldhaleei, Wafa A , Wallace, Michael B , Bhagavathula, Akshaya Srikanth , Aldhaleei, Wafa Ali

Cancers | August 20, 2024 | Volume: 16 | Issue: 16 | Pages: 2883

10.3390/cancers16162883 | PMID 39199654 Get It

The incidence of early-onset colorectal cancer (EO-CRC) in individuals under 50 years old is rapidly increasing in the United States. This study aims to evaluate EO-CRC incidence rates using data from the Global Burden of Disease Study (GBD) 2021, providing insights into trends from 1990 to 2021. We employed an age–period–cohort (APC) model analysis to estimate the effects of age, time period, and birth cohort on EO-CRC incidence. Our findings indicate that the number of EO-CRC cases rose from 6256 (95% UI: 6059–6456) in 1990 to 9311 (95% UI: 8859–9744) in 2021, a 49% increase from 1990 to 2021. The age-standardized incidence rate per 100,000 population increased by 34% during this period. The net drift in females (0.22%, 95% CI: 0.20–0.24) was slightly higher than in males (0.21%, 95% CI: 0.19–0.23) (p = 0.45). The APC analysis revealed that being over 25 years old, the period from 2005–2021, and being born after 1983 negatively impacted EO-CRC incidence rates, with a sharp rise after 2000 and a reduction among females from 2017 to 2021. Our study highlights the need for targeted prevention strategies and further research to understand these trends.
Unsupervised Machine Learning to Identify Subphenotypes Among Cardiac Intensive Care Unit Patients with Heart Failure
Reddy, Yogesh N.V. , Soussi, Sabri , Crespo‐Diaz, Ruben , Patel, Parag C. , Lawler, Patrick R. , Crespo-Diaz, Ruben, Dunlay, Shannon M. , Nishimura, Rick , Lawler, Patrick , Jentzer, Jacob C. , Mebazaa, Alexandre

ESC Heart Failure | August 19, 2024 | Volume: 11 | Issue: 6 | Pages: 4242-4256

10.1002/ehf2.15027 | PMID 39160644 Get It

Abstract Aims Hospitalized patients with heart failure (HF) are a heterogeneous population, with multiple phenotypes proposed. Prior studies have not examined the biological phenotypes of critically ill patients with HF admitted to the contemporary cardiac intensive care unit (CICU). We aimed to leverage unsupervised machine learning to identify previously unknown HF phenotypes in a large and diverse cohort of patients with HF admitted to the CICU. Methods We screened 6008 Mayo Clinic CICU patients with an admission diagnosis of HF from 2007 to 2018 and included those without missing values for common laboratory tests. Consensus k-means clustering was performed based on 10 common admission laboratory values (potassium, chloride, anion gap, blood urea nitrogen, haemoglobin, red blood cell distribution width, mean corpuscular volume, platelet count, white blood cell count and neutrophil-to-lymphocyte ratio). In-hospital mortality was evaluated using logistic regression, and 1 year mortality was evaluated using Cox proportional hazard models after multivariable adjustment. Results Among 4877 CICU patients with HF who had complete admission laboratory data (mean age 69.4 years, 38.4% females), we identified five clusters with divergent demographics, comorbidities, laboratory values, admission diagnoses and use of critical care therapies. We labelled these clusters based on the characteristic laboratory profile of each group: uncomplicated (25.7%), iron-deficient (14.5%), cardiorenal (18.4%), inflamed (22.3%) and hypoperfused (19.2%). In-hospital mortality occurred in 10.7% and differed between the phenotypes: uncomplicated, 2.7% (reference); iron-deficient, 8.1% [adjusted odds ratio (OR) 2.18 (1.38–3.48), P &lt; 0.001]; cardiorenal, 10.3% [adjusted OR 2.11 (1.37–3.32), P &lt; 0.001]; inflamed, 12.5% [adjusted OR 1.79 (1.18–2.76), P = 0.007]; and hypoperfused, 21.9% [adjusted OR 4.32 (2.89–6.62), P &lt; 0.001]. These differences in mortality between phenotypes were consistent when patients were stratified based on demographics, aetiology, admission diagnoses, mortality risk scores, shock severity and systolic function. One-year mortality occurred in 31.5% and differed between the phenotypes: uncomplicated, 11.9% (reference); inflamed, 26.8% [adjusted hazard ratio (HR) 1.56 (1.27–1.92), P &lt; 0.001]; iron-deficient, 33.8% [adjusted HR 2.47 (2.00–3.04), P &lt; 0.001]; cardiorenal, 41.2% [adjusted HR 2.41 (1.97–2.95), P &lt; 0.001]; and hypoperfused, 52.3% [adjusted HR 3.43 (2.82–4.18), P &lt; 0.001]. Similar findings were observed for post-discharge 1 year mortality. Conclusions Unsupervised machine learning clustering can identify multiple distinct clinical HF phenotypes within the CICU population that display differing mortality profiles both in-hospital and at 1 year. Mortality was lowest for the uncomplicated HF phenotype and highest for the hypoperfused phenotype. The inflamed phenotype had comparatively higher in-hospital mortality yet lower post-discharge mortality, suggesting divergent short-term and long-term prognosis.